No Data
Stifel Nicolaus Reaffirms Their Buy Rating on Zymeworks (ZYME)
Zymeworks Price Target Maintained With a $10.00/Share by HC Wainwright & Co.
Zymeworks Price Target Maintained With a $10.00/Share by HC Wainwright & Co.
HC Wainwright & Co. Reiterates Neutral on Zymeworks, Maintains $10 Price Target
HC Wainwright & Co. analyst Robert Burns reiterates Zymeworks (NASDAQ:ZYME) with a Neutral and maintains $10 price target.
Zymeworks Price Target Cut to $16.00/Share From $17.00 by Citigroup
Zymeworks Price Target Cut to $16.00/Share From $17.00 by Citigroup
Citi: Maintains the Zymeworks (ZYME.US) rating, adjusted from buy to buy rating, and adjusted the target price from $17.00 to $16.00.
Citi: Maintains the Zymeworks (ZYME.US) rating, adjusted from buy to buy rating, and adjusted the target price from $17.00 to $16.00.
Zymeworks Is Maintained at Overweight by Wells Fargo
Zymeworks Is Maintained at Overweight by Wells Fargo